FDA-Drug2026-09-02Class IICHEMICAL

Accord Healthcare Levothyroxine Sodium 125 mcg tablets recalled for subpotent drug

LABEL MIX UPNationwide distributionDrugs

What this means

Accord Healthcare is recalling specific lots of Levothyroxine Sodium 125 mcg tablets because they may contain less active ingredient than labeled. This means the medication may not work as intended for patients taking it to manage thyroid conditions.

  • Check if you have one of the affected lots: D2401983 (expires 08/31/2026), D2402640 or D2402641 (expires 11/30/2026), or D2500224 (expires 01/31/2027)
  • Contact your pharmacy or doctor if you have one of these lots
  • Do not stop taking your medication without talking to your doctor
  • Your doctor may want to check your thyroid levels or switch you to another supply
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Subpotent Drug

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the United States
Affected count
N/A
Manufactured in
8041 Arco Corporate Dr Ste 200, N/A, Raleigh, NC, United States
Products
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-453-17.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0781-2026

More Accord Healthcare recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.